ADARx Pharmaceuticals, Inc. (ADRX)

NASDAQ

$18.00

$+0.20

(+1.13%)

Previous Close: ⁦$17.68⁩

Market Closed

ADARx Pharmaceuticals, Inc. (ADRX) Live Price Chart

Last updated: ⁦2026-10-12 02:57:00⁩. Prices reflect the latest closing data and will resume updating on the next trading day. Stock price data is sourced from Massive.

Summary

ADARx Pharmaceuticals, Inc. (ADRX) operates in the -- sector and is listed on NASDAQ. The stock is currently priced at $18.00, with a market capitalization of $1.90B and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $16.64 to $23.21. This page covers its latest market performance, valuation, price trends and company information.

Key Market Data

Market Cap	$1.90B
Open	$17.70
Day's High	$30.87
Day's Low	$12.74
Previous Close	$17.68
Volume	630.28K
Average Volume	1.20M
P/E Ratio	--
52-Week High	$23.21
52-Week Low	$16.64
Dividend Yield	--
Earnings Date	--

ADARx Pharmaceuticals, Inc. (ADRX) Latest Closing Stock Price

ADARx Pharmaceuticals, Inc. (ADRX) last closed at $17.68 as of 2026-10-09 23:56:00, unchanged from the previous close of $17.68.

During the latest regular trading session, ADRX traded between $12.74 and $30.87, with a volume of 630.28K shares. The closing price was near the lower end and near the lower end of its 52-week range.

ADARx Pharmaceuticals, Inc. (ADRX) 7-Day Stock Price Change

Over the past seven days, ADARx Pharmaceuticals, Inc. (ADRX) moved from $19.54 to $18.00, representing a decline of 7.88% ($1.54).

The stock traded between $16.64 and $20.77 during the period. The latest price is near the lower end of the 7-day range, indicating strong downward.

The average daily volume was 808.93 thousand shares, down versus the previous seven-day period, indicating lower trading activity.

ADRX 52-Week Price Position

Position in Range: 20.7%

52W Low$16.64

52W High$23.21

ADRX is currently trading at $18.00, placing it 20.7% of the way from its 52-week low of $16.64 to its 52-week high of $23.21. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.

What is ADARx Pharmaceuticals, Inc. (ADRX)?

Adarx Pharmaceuticals Inc is a late-clinical stage biotechnology company focused on developing next-generation siRNA therapeutics designed to treat a broad spectrum of diseases. Its pipeline includes three clinical-stage programs and two advanced preclinical programs. The three hepatic-targeted programs are agazisiran, onvuzosiran, and ADX-626, while the two extrahepatic-targeted programs are ADX-077 and ADX-199.

ADARx Pharmaceuticals, Inc. Information

Exchange	NASDAQ
Company Website	https://www.adarx.com

How to Buy ADARx Pharmaceuticals, Inc. (ADRX) Stock on MEXC

Eligible investors can buy real shares of ADARx Pharmaceuticals, Inc. (ADRX) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.

Step 1: Open and Verify Your RealStocks Account

Log in to the MEXC App, go to Trade → RealStocks, and select Open Account. Complete the required account-opening and identity verification process with MEXC's partner licensed broker.

Step 2: Transfer USDT to Your RealStocks Account

Go to Wallets → RealStocks and transfer USDT from your Spot Account to your RealStocks Account. RealStocks are quoted in USD, while account funding can be completed using USDT.

Step 3: Search for ADRX and Place Your Order

Open the RealStocks trading page and search for ADRX. Select a market or limit order, enter the price and quantity as required, review the order details, and submit your order. Once filled, the corresponding real shares will be held in your RealStocks Account.

Frequently Asked Questions (FAQ)

1.What is ADARx Pharmaceuticals, Inc. (ADRX) stock price today?

ADARx Pharmaceuticals, Inc. (ADRX) is currently trading at $ 18.00, up 1.84% ($0.32) from the previous close of $ 17.68. Intraday prices update in real time during regular trading hours.

2.Is ADRX stock going up or down today?

As of 2026-10-09 23:56:00, ADRX is trading at $ 18.00, up 1.84% ($0.32) from its previous close of $ 17.68. The stock has traded between $ 12.74 and $ 30.87 during today’s regular session. Past price movements do not guarantee future results.

3.What is ADRX pre-market price?

As of 2026-10-09 23:56:00, ADRX is trading at $ 16.98 in pre-market trading, down 3.93% ($0.70) from the previous close of $ 17.68. Pre-market prices reflect trading activity before the regular session opens and may experience lower liquidity and higher volatility.

4.What is ADRX after-hours price?

As of 2026-10-09 23:56:00, ADRX is trading at $ 17.81 in after-hours trading, up 0.74% ($0.13) from the regular-session close of $ 17.68. After-hours prices may differ from the regular session’s opening price due to lower liquidity and wider bid-ask spreads.

5.Is ADRX stock trading now?

ADRX trades on the NASDAQ exchange during regular hours, Monday through Friday, 9:30 AM to 4:00 PM ET, excluding public holidays. Pre-market and after-hours trading are also available through select brokers outside these hours.

6.Where does ADRX sit relative to its 52-week high and low?

Over the past 52 weeks, ADRX has traded between a low of $ 16.64 and a high of $ 23.21. At $ 18.00, the stock is positioned 20.7% of the way from its 52-week low to its 52-week high, providing context for its current price within the one-year trading range.

7.What sector is ADARx Pharmaceuticals, Inc. in?

ADARx Pharmaceuticals, Inc. (ADRX) operates in the -- sector. Sector classification helps investors compare it with companies exposed to similar market trends and competitive conditions.

8.What is ADARx Pharmaceuticals, Inc.'s market capitalization and where is it listed?

ADARx Pharmaceuticals, Inc. is listed on the NASDAQ exchange with a market capitalization of $ 1.90B. Market cap reflects the total market value of all outstanding shares and is commonly used to classify stocks by size.

9.How is ADRX valued in terms of P/E ratio and EPS?

ADRX trades at a P/E ratio of --, based on trailing-twelve-month EPS of --. P/E ratio compares the stock price to earnings per share and is a common starting point for assessing valuation relative to peers.

10.Does ADARx Pharmaceuticals, Inc. pay a dividend?

ADARx Pharmaceuticals, Inc. pays an indicated annual cash dividend of -- per share, with a current dividend yield of --% based on the latest share price. Dividend policies are subject to change at the board's discretion.